Given the restrictions on the qualification criteria I would assume this would be aimed at VIV patients given that our valve actually improves the first valve to better than it was when it first went in. Inhumane not to use DurAVR? This is a very exciting possibility.
Given the restrictions on the qualification criteria I would...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$6.00 |
Change
-0.030(0.50%) |
Mkt cap ! $92.99M | |||
| Open | High | Low | Value | Volume |
| $6.01 | $6.03 | $5.84 | $85.53K | 14.32K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 333 | $6.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.25 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| AVR (ASX) Chart |